• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种经过验证的高效液相色谱法,用于测定大鼠血浆和尿液中的溴吡斯的明、对乙酰氨基酚、乙酰水杨酸和咖啡因。

A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine.

作者信息

Abu-Qare A W, Abou-Donia M B

机构信息

Department of Pharmacology and Cancer Biology, Duke University Medical Center, PO Box 3813, Durham, NC 27710, USA.

出版信息

J Pharm Biomed Anal. 2001 Dec;26(5-6):939-47. doi: 10.1016/s0731-7085(01)00448-4.

DOI:10.1016/s0731-7085(01)00448-4
PMID:11600306
Abstract

A method was developed for the separation and quantification of the anti-nerve agent pyridostigmine bromide (PB; 3-dimethylaminocarbonyloxy-N-methyl pyridinium bromide), the analgesic drugs acetaminophen and acetylsalicylic acid, and the stimulant caffeine (3,7-dihydro-1,3,7-trimethyl-1-H-purine-2,6-dione) in rat plasma and urine. The compounds were extracted using C(18) Sep-Pak(R) cartridges then analyzed by high performance liquid chromatography (HPLC) with reversed phase C18 column, and UV detection at 280 nm. The compounds were separated using gradient of 1-85% acetonitrile in water (pH 3.0) at a flow rate ranging between 1 and 1.5 ml/min in a period of 14 min. The retention times ranged from 8.8 to 11.5 min. The limits of detection were ranged between 100 and 200 ng/ml, while limits of quantitation were 150-200 ng/ml. Average percentage recovery of five spiked plasma samples were 70.9+/-9.5, 73.7+/-9.8, 88.6+/-9.3, 83.9+/-7.8, and from urine 69.1+/-8.5, 74.5+/-8.7, 85.9+/-9.8, 83.2+/-9.3, for pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine, respectively. The relationship between peak areas and concentration was linear over range between 100 and 1000 ng/ml. The resulting chromatograms showed no interfering peaks from endogenous plasma or urine components. This method was applied to analyze these compounds following oral administration in rats.

摘要

已开发出一种用于分离和定量大鼠血浆及尿液中抗神经毒剂溴化吡啶斯的明(PB;3 - 二甲基氨基甲酰氧基 - N - 甲基吡啶溴化物)、镇痛药对乙酰氨基酚和乙酰水杨酸以及兴奋剂咖啡因(3,7 - 二氢 - 1,3,7 - 三甲基 - 1 - H - 嘌呤 - 2,6 - 二酮)的方法。使用C(18) Sep - Pak(R) 柱进行化合物萃取,然后通过配备反相C18柱的高效液相色谱(HPLC)进行分析,并在280 nm处进行紫外检测。在14分钟内,以1至1.5 ml/分钟的流速,使用1 - 85%乙腈水溶液(pH 3.0)的梯度对化合物进行分离。保留时间在8.8至11.5分钟之间。检测限在100至200 ng/ml之间,定量限为150 - 200 ng/ml。五个加标血浆样本中溴化吡啶斯的明、对乙酰氨基酚、乙酰水杨酸和咖啡因的平均回收率分别为70.9±9.5、73.7±9.8、88.6±9.3、83.9±7.8,尿液中的平均回收率分别为69.1±8.5、74.5±8.7、85.9±9.8、83.2±9.3。峰面积与浓度之间的关系在100至1000 ng/ml范围内呈线性。所得色谱图未显示来自内源性血浆或尿液成分的干扰峰。该方法用于分析大鼠口服给药后的这些化合物。

相似文献

1
A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine.一种经过验证的高效液相色谱法,用于测定大鼠血浆和尿液中的溴吡斯的明、对乙酰氨基酚、乙酰水杨酸和咖啡因。
J Pharm Biomed Anal. 2001 Dec;26(5-6):939-47. doi: 10.1016/s0731-7085(01)00448-4.
2
Simultaneous determination of pyridostigmine bromide, N,N-diethyl-m-toluamide, permethrin, and their metabolites in rat plasma and urine by high-performance liquid chromatography.高效液相色谱法同时测定大鼠血浆和尿液中溴吡斯的明、N,N-二乙基间甲苯酰胺、氯菊酯及其代谢物
J Chromatogr B Biomed Sci Appl. 2000 Dec 1;749(2):171-8. doi: 10.1016/s0378-4347(00)00407-2.
3
Chromatographic method for the determination of diazepam, pyridostigmine bromide, and their metabolites in rat plasma and urine.用于测定大鼠血浆和尿液中地西泮、溴吡斯的明及其代谢物的色谱法。
J Chromatogr B Biomed Sci Appl. 2001 Apr 25;754(2):503-9. doi: 10.1016/s0378-4347(01)00040-8.
4
High-performance liquid chromatographic determination of pyridostigmine bromide, nicotine, and their metabolites in rat plasma and urine.高效液相色谱法测定大鼠血浆和尿液中的溴吡斯的明、尼古丁及其代谢产物。
J Chromatogr Sci. 2001 Jul;39(7):287-92. doi: 10.1093/chromsci/39.7.287.
5
Development of a high-performance liquid chromatographic method for the quantification of chlorpyrifos, pyridostigmine bromide, N,N-diethyl-m-toluamide and their metabolites in rat plasma and urine.建立一种高效液相色谱法,用于定量测定大鼠血浆和尿液中的毒死蜱、溴吡斯的明、N,N-二乙基间甲苯酰胺及其代谢物。
J Chromatogr B Biomed Sci Appl. 2001 Apr 25;754(2):533-8. doi: 10.1016/s0378-4347(01)00028-7.
6
Determination of depleted uranium, pyridostigmine bromide and its metabolite in plasma and urine following combined administration in rats.大鼠联合给药后血浆和尿液中贫铀、溴化吡啶斯的明及其代谢物的测定。
J Pharm Biomed Anal. 2001 Sep;26(2):281-9. doi: 10.1016/s0731-7085(01)00403-4.
7
LC method for the analysis of acetylsalicylic acid, caffeine and codeine phosphate in pharmaceutical preparations.
J Pharm Biomed Anal. 2001 Apr;25(1):93-101. doi: 10.1016/s0731-7085(00)00488-x.
8
Validated stability-indicating reversed-phase-HPLC method for simultaneous determination of orphenadrine citrate, caffeine and aspirin.用于同时测定枸橼酸奥芬那君、咖啡因和阿司匹林的经验证的稳定性指示反相高效液相色谱法。
Chem Pharm Bull (Tokyo). 2012;60(11):1426-36. doi: 10.1248/cpb.c12-00596.
9
Sequential injection chromatographic determination of paracetamol, caffeine, and acetylsalicylic acid in pharmaceutical tablets.序贯注射色谱法测定药片中的对乙酰氨基酚、咖啡因和乙酰水杨酸。
J Sep Sci. 2004 May;27(7-8):529-36. doi: 10.1002/jssc.200301644.
10
Pharmaceutical analysis in solids using front face fluorescence spectroscopy and multivariate calibration with matrix correction by piecewise direct standardization.固体药物分析中的前向荧光光谱法和多元校正与分段直接标准化的矩阵校正。
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Feb 15;103:311-8. doi: 10.1016/j.saa.2012.10.074. Epub 2012 Nov 7.

引用本文的文献

1
An on-site and portable electrochemical sensing platform based on spinel zinc ferrite nanoparticles for the quality control of paracetamol in pharmaceutical samples.一种基于尖晶石型铁酸锌纳米颗粒的现场便携式电化学传感平台,用于药物样品中扑热息痛的质量控制。
Nanoscale Adv. 2023 Nov 16;6(1):256-267. doi: 10.1039/d3na00749a. eCollection 2023 Dec 19.
2
Simultaneous determination of tramadol and paracetamol in human plasma using LC-MS/MS and application in bioequivalence study of -fixed-dose combination.采用 LC-MS/MS 法同时测定人血浆中曲马多和对乙酰氨基酚的浓度及其在复方固定剂量制剂生物等效性研究中的应用。
Ann Med. 2023;55(2):2270502. doi: 10.1080/07853890.2023.2270502. Epub 2023 Oct 19.